0001140361-16-062844.txt : 20160502 0001140361-16-062844.hdr.sgml : 20160502 20160502172608 ACCESSION NUMBER: 0001140361-16-062844 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160429 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20160502 DATE AS OF CHANGE: 20160502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASCULAR SOLUTIONS INC CENTRAL INDEX KEY: 0001030206 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411859679 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27605 FILM NUMBER: 161612849 BUSINESS ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 BUSINESS PHONE: 7636564300 MAIL ADDRESS: STREET 1: 6464 SYCAMORE COURT NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55369 8-K 1 form8k.htm VASCULAR SOLUTIONS, INC. 8-K 4-29-2016
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report:  April 29, 2016
 
(date of earliest event reported)
 
 VASCULAR SOLUTIONS, INC.
 
(Exact name of registrant as specified in its charter)
 
Commission File Number: 0-27605
 
 
Minnesota
  
41-1859679
(State or other jurisdiction of incorporation)
  
(IRS Employer Identification No.)
 
6464 Sycamore Court North
Minneapolis, Minnesota 55369
(Address of principal executive offices)
 
 (763) 656-4300
(Registrant’s telephone number, including area code)
 
 Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ( 17 CFR 240.13e-4(c))
 
Item 5.07. Submission of Matters to a Vote of Security Holders.
 
At the Annual Meeting of Shareholders of Vascular Solutions, Inc. (the “Company”) held on April 29, 2016, the Company’s shareholders approved each of the following proposals, which were set forth in the Proxy Statement for the 2016 Annual Meeting of Shareholders:
 
Proposal 1
 
The Company’s shareholders elected each of the seven director nominees to a one-year term and until the director’s successor is elected and qualified (except in the case of earlier death, resignation or removal) as follows:
 
 
FOR
WITHHOLD
  
BROKER NON-VOTE
Martin Emerson
13,271,336
257,507
  
2,748,315
John Erb
13,142,084
386,759
  
2,748,315
Richard Kramp
13,456,907
71,936
  
2,748,315
Richard Nigon
12,030,478
1,498,365
  
2,748,315
Paul O’Connell
13,441,614
87,229
  
2,748,315
Howard Root
13,443,019
85,824
  
2,748,315
Jorge Saucedo
13,269,586
259,257
  
2,748,315
 
Proposal 2
 
The Company’s shareholders ratified the appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2016:
 
FOR
AGAINST
ABSTAIN
BROKER NON-VOTE
15,960,987
305,017
11,154
0
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
VASCULAR SOLUTIONS, INC.
       
Date:  May 2, 2016
By:
/s/ Gordon Weber
  
   
Gordon Weber
  
   
Its: Secretary